Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Patients Type 1 and 2”

125 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 125 results

Not applicableStudy completedNCT06867965
What this trial is testing

Feasibility Study of a Novel Subcutaneous Continuous Glucose Monitoring System in Diabetics

Who this might be right for
Diabetes
EyeSense GmbH 8
Large-scale testing (Phase 3)Study completedNCT00566189
What this trial is testing

New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I

Who this might be right for
Diabetes Mellitus, Type 2Insulin ResistanceObesity
University of Campinas, Brazil 36
Early research (Phase 1)Study completedNCT01147861
What this trial is testing

Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 Diabetics

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 39
Not applicableLooking for participantsNCT07245082
What this trial is testing

Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
National Taiwan University Hospital 2,000
Testing effectiveness (Phase 2)Study completedNCT00885118
What this trial is testing

4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 100
Testing effectiveness (Phase 2)UnknownNCT05333835
What this trial is testing

A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 455
Post-approval studies (Phase 4)Study completedNCT02299050
What this trial is testing

Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy

Who this might be right for
Type 2 Diabetes
The University of Texas Health Science Center at San Antonio 23
Large-scale testing (Phase 3)Study completedNCT00602472
What this trial is testing

BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,058
Not applicableStudy completedNCT02045563
What this trial is testing

Genetic Polymorphisms, Steatosis and Diabetes

Who this might be right for
Type 1 and 2 Diabetes
Centre Hospitalier Universitaire Dijon 507
Testing effectiveness (Phase 2)Study completedNCT00320060
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 128
Post-approval studies (Phase 4)UnknownNCT05089942
What this trial is testing

Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021

Who this might be right for
type1diabetesType2 Diabetes
Zhejiang Provincial People's Hospital 16
Early research (Phase 1)Study completedNCT01396161
What this trial is testing

PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 64
Testing effectiveness (Phase 2)Ended earlyNCT01113801
What this trial is testing

A Study in Participants With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetic Glomerulosclerosis
Eli Lilly and Company 417
Testing effectiveness (Phase 2)Study completedNCT04265261
What this trial is testing

Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Hoffmann-La Roche 139
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Post-approval studies (Phase 4)Study completedNCT02276196
What this trial is testing

Effect of LIXIsenatide on the Renal System

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetes Mellitus+1 more
Amsterdam UMC, location VUmc 40
Early research (Phase 1)Study completedNCT04990427
What this trial is testing

CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Chronic Kidney Diseases
Lisata Therapeutics, Inc. 6
Not applicableEnded earlyNCT00689026
What this trial is testing

Efficacy of Lubiprostone in Combination With Standard PEG Preparation

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Augusta University 60
Not applicableEnded earlyNCT03872089
What this trial is testing

Transient Thermal Behavior and Diabetic Foot

Who this might be right for
Diabetic Patients Type 1 and 2Podologic Grade From 0 to 3
University Hospital, Montpellier 45
Early research (Phase 1)Study completedNCT01474161
What this trial is testing

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

Who this might be right for
Type 2 DiabetesDiabetes Mellitus, Type 2Metabolic Diseases+3 more
Genfit 96
Load More Results